Skip to main content

After major venture round, Rockville’s RegenxBio Inc. files for IPO – Washington Business Journal

By August 17, 2015News
regenxbio-logo

regenxbio-logo

Mere months after a major venture capital fundraise, Rockville-based biotech RegenxBio Inc. says it’s ready to go public. UPCOMING EVENTS AUGUST 18, 2015 , 11:45AM Washington Business Journal: Lead Generation Seminar

In an initial regulatory filing Monday with the Securities and Exchange Commission, the company said it would trade on the Nasdaq exchange under the ticker symbol RGNX. It has yet to say how much it plans to raise and set either a price for the stock or date for the initial public offering. Morgan Stanley & Co. LLC (NYSE: MS), BofA Merrill Lynch, Piper Jaffray and Chardan Capital Markets LLC will manage the IPO.

{iframe}http://www.bizjournals.com/washington/blog/2015/08/venture-backed-md-biotech-files-for-ipo.html?ana=e_du_pap&s=article_du&ed=2015-08-17&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1439839604{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.